Monday, January 7, 2013

New job Omrix, a leading Bio-Pharmaceutical company, is seeking a RA Globalization Specialist to the R & D dept at Rechovot. Please send your cv to: jobs@omrix.co.il

LinkedIn Following

  • Group: משרות ביוטק בין חברים, לפני שמתפרסמות בלוחות וחברות השמה
  • Subject: Omrix, a leading Bio-Pharmaceutical company, is seeking a RA Globalization Specialist to the R & D dept at Rechovot. Please send your cv to: jobs@omrix.co.il

Hila Benayoun posted a job: Omrix, a leading Bio-Pharmaceutical company, is seeking a RA Globalization Specialist to the R & D dept at Rechovot. Please send your cv to: jobs@omrix.co.il

"Job Description: We’re Hiring ! Omrix, a leading bio-pharmaceutical company, is seeking a RA Globalization Specialist. The position includes Review, approval and submission of products labeling and packaging materials for all J&J affiliates in Globalization Countries, Provide RA support for generation and management of submissions of products' medical device files to J&J affiliates in Globalization countries; Pre-approval and Post-approval legalization and Maintenance of certificates associated with Biologics and Medical Device products' license for all Globalization countries. The position is temporary for 8 months with a high possibility for a permanent position in the future. Qualifications: - Relevant Academic Degree, preferably Ms.c and from the life sciences field. - Proven knowledge and former experience in Medical Device Regulatory Affairs (At least one year). - Fluent English, with excellent English writing skills. - Excellent communication, interpersonal and organizational skills. Team Player. - Computer skills – Proficient with all Microsoft Office applications."

Don't want to get activity notifications: Change your following people settings »

Learn more about following people's activity

 
This email was intended for Anat Levy (Marcom manager, JobHunt). Learn why we included this. © 2012, LinkedIn Corporation. 2029 Stierlin Ct. Mountain View, CA 94043, USA
 

No comments:

Post a Comment